Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-06 Sale | 2025-03-10 4:02 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 3,453 | $30 | $103,591 | 175,691 (Direct) | View |
| 2025-03-06 Sale | 2025-03-10 4:01 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 5,643 | $30 | $169,299 | 142,063 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 6:48 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 86,067 | $28.19 | $2,426,634 | 108,137 (Direct) | View |
| 2025-01-10 Sale | 2025-01-14 4:12 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 27,500 | $33.04 | $908,628 | 119,184 (Direct) | View |
| 2024-09-13 Sale | 2024-09-17 4:32 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 9,593 | $36.62 | $351,320 | 53,816 (Direct) | View |
| 2024-09-05 Sale | 2024-09-06 5:52 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 20,225 | $38.26 | $773,792 | 119,184 (Direct) | View |
| 2024-06-03 Sale | 2024-06-05 4:06 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 25,000 | $32.57 | $814,180 | 139,409 (Direct) | View |
| 2024-05-28 Sale | 2024-05-29 4:29 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 19,710 | $34.21 | $674,368 | 130,845 (Direct) | View |
| 2024-05-23 Sale | 2024-05-28 4:22 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 108,016 | $33.91 | $3,662,548 | 129,693 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 7:20 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director | 28,985 | $32.3 | $936,311 | 52,468 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 4:26 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 995 | $36.76 | $36,580 | 63,409 (Direct) | View |
| 2024-02-26 Sale | 2024-02-28 4:14 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 10,000 | $36.43 | $364,270 | 138,918 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:19 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 23,560 | $32.28 | $760,519 | 111,322 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 4:36 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 4,357 | $30.38 | $132,377 | 291,875 (Direct) | View |
| 2023-12-18 Sale | 2023-12-20 5:51 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 68,768 | $30.18 | $2,075,086 | 406,120 (Direct) | View |
| 2023-11-27 Sale | 2023-11-29 4:32 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 25,600 | $25.78 | $660,014 | 119,518 (Direct) | View |
| 2023-06-26 Sale | 2023-06-28 4:08 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 17,984 | $21.72 | $390,633 | 119,518 (Direct) | View |
| 2023-06-01 Sale | 2023-06-02 7:08 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 62,544 | $21.84 | $1,366,182 | 275,000 (Direct) | View |
| 2023-05-30 Sale | 2023-06-01 4:15 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 62,543 | $21.88 | $1,368,704 | 337,544 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-04 Exercise | 2025-03-06 6:48 pm | N/A 2028-04-04 | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 40,000 | $0 | 108,137 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 6:48 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 40,000 | $24.03 | 108,137 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 4,820 | $0 | 50,328 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 39,075 | $0 | 87,742 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 5,897 | $30.52 | 87,742 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 71,427 | $0 | 147,706 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 29,623 | $30.52 | 147,706 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 78,725 | $0 | 179,144 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 30,426 | $30.52 | 179,144 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 4:09 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 69,995 | $0 | 154,204 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:09 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 34,975 | $30.52 | 154,204 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-05 5:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Lurker Nancy Director | 12,726 | $0 | 12,726 (Direct) | View |
| 2025-01-10 Exercise | 2025-01-14 4:12 pm | N/A 2030-02-05 | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 27,500 | $0 | 119,184 (Direct) | View |
| 2025-01-10 Exercise | 2025-01-14 4:12 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 27,500 | $21.34 | 119,184 (Direct) | View |
| 2024-11-12 Option Award | 2024-11-14 4:50 pm | N/A 2034-11-12 | COLLEGIUM PHARMACEUTICAL INC | COLL | Karnani Vikram President and CEO | 236,316 | $0 | 236,316 (Direct) | View |
| 2024-05-23 Exercise | 2024-05-28 4:22 pm | N/A 2028-04-04 | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 75,000 | $0 | 129,693 (Direct) | View |
| 2024-05-23 Exercise | 2024-05-28 4:22 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 75,000 | $24.03 | 129,693 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:23 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | SANTINI GINO Director | 7,693 | $0 | 75,656 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:23 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Melincoff Gwen A Director | 7,693 | $0 | 52,468 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:23 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director | 7,693 | $0 | 49,365 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:22 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Freund John Gordon Director | 7,693 | $0 | 95,881 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:22 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Fallon John A. Director | 7,693 | $0 | 54,843 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:22 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Balice-Gordon Rita J. Director | 7,693 | $0 | 46,488 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:21 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 7,693 | $0 | 45,508 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 7:20 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director | 28,985 | $5.73 | 52,468 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 7:20 pm | N/A 2025-03-19 | COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director | 28,985 | $0 | 52,468 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-16 7:20 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director | 7,693 | $0 | 52,468 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 4:15 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 26,321 | $33.7 | 150,555 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:15 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 71,456 | $0 | 150,555 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 29,690 | $33.7 | 148,918 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 67,286 | $0 | 148,918 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 3,199 | $33.7 | 64,404 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 35,423 | $0 | 64,404 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 31,756 | $33.7 | 164,409 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 76,647 | $0 | 164,409 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 4:13 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 128,867 | $33.7 | 444,867 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 4:13 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 298,734 | $0 | 444,867 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 4:36 pm | N/A 2030-02-05 | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 4,357 | $0 | 291,875 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 4:36 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 4,357 | $21.34 | 291,875 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-20 5:51 pm | N/A 2030-02-05 | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 68,768 | $0 | 406,120 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-20 5:51 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Ciaffoni Joseph President and CEO | 68,768 | $21.34 | 406,120 (Direct) | View |
| 2023-11-27 Exercise | 2023-11-29 4:32 pm | N/A 2029-01-25 | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 25,600 | $0 | 119,518 (Direct) | View |
| 2023-11-27 Exercise | 2023-11-29 4:32 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 25,600 | $15.9 | 119,518 (Direct) | View |